Fitt Insider Neko Health's US launch, Tom Brady co-signs GLP-1s, Women's health scales up
Jan 14, 2026
Neko Health is set to open its first U.S. location in NYC, offering a groundbreaking 60-minute preventative body scan after an impressive $260M fundraising. Tom Brady is now the Chief Wellness Officer at eMed, joining a star-studded list endorsing GLP-1 weight-loss solutions. Meanwhile, Pomelo Care raises $92M to enhance women's and children's health care, now supporting nearly 7% of U.S. births. The digital health sector saw a boom in 2024, with startups attracting $14.2B, as investors flock to platforms focused on prevention and wearable tech.
AI Snips
Chapters
Transcript
Episode notes
Prevention-First Diagnostics Enter U.S.
- Neko Health is launching its first U.S. location in NYC this spring after scaling in Europe and the UK.
- The company's 60-minute non-invasive scans and 300K+ signups show growing demand for prevention-first diagnostics.
Celebrity Backing Accelerates GLP-1 Adoption
- Tom Brady joined eMed as Chief Wellness Officer to support employer-delivered GLP-1 care amid expanding access to weight-loss drugs.
- Celebrity endorsements from athletes indicate mainstreaming of GLP-1 platforms and wellness repositioning.
Outcome-Driven Women's Care Scales Fast
- PomeloCare raised $92M at a $1.7B valuation to expand from maternity into broader women's and children's care.
- Serving nearly 7% of U.S. births shows investor confidence in outcome-driven, scalable virtual maternity care.